Congenital Heart Disease in Patients With Cleft Lip/Palate and Its Impact on Cleft Management

Beina Azadgoli1, Naikhoba C O Munabi1, Artur Fahradyan2

  • 1Division of Plastic and Reconstructive Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.

Insights

Congenital heart disease (CHD) is more common in patients with cleft lip and/or palate (CL/P), especially those with cleft palate. CHD requires careful management alongside cleft treatment to minimize complications like fistulas.

Area of Science:

  • Craniofacial Surgery
  • Pediatric Cardiology
  • Medical Genetics

Background:

  • Congenital heart disease (CHD) is a known comorbidity in patients with cleft lip and/or palate (CL/P).
  • The prevalence and specific associations of CHD within the CL/P population require further elucidation.

Purpose of the Study:

  • To evaluate the characteristics of CHD in patients with CL/P.
  • To assess the association between CHD and cleft outcomes.

Main Methods:

  • Retrospective review of 575 patients with CL/P undergoing primary cleft treatment (2009-2015).
  • Analysis of patient demographics, prenatal/birth characteristics, CL/P details, syndromic status, and postoperative complications.
  • Comparison of patients with (+CHD) versus without (-CHD) congenital heart disease using statistical tests.

Main Results:

  • 14.4% of patients with CL/P (83/575) had CHD.
  • CHD rates were significantly higher in patients with cleft palate (CP) compared to other cleft types (P = .009).
  • Most CHD cases (97.6%) were diagnosed before cleft treatment; 27.7% required cardiac surgery prior to cleft repair. CHD was linked to delayed CP repair and increased fistula rates in isolated CP patients.

Conclusions:

  • Congenital heart disease is notably more prevalent in CL/P patients, particularly those with CP.
  • Severe CHD is typically diagnosed and managed before cleft care.
  • Postoperative fistulas may be more frequent in CL/P patients with CHD, necessitating careful surgical planning and patient optimization.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
368
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
258
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
169
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
191
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
638
Cardiopulmonary Resuscitation II: ACLS Airway Management01:22

Cardiopulmonary Resuscitation II: ACLS Airway Management

Airway management is a key skill in emergency and critical care settings, as maintaining a clear airway is essential for adequate oxygenation and ventilation.Head Tilt-Chin Lift TechniqueThe head tilt-chin lift maneuver is an essential technique primarily used in patients without suspected cervical spine injuries. To perform this maneuver, one hand is placed on the patient’s forehead, and gentle pressure is applied backward to tilt the head. The fingertips of the other hand are positioned...
401